Search
                    Crohn's Disease Paid Clinical Trials in Pennsylvania
A listing of 14  Crohn's Disease  clinical trials  in Pennsylvania  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            13 - 14 of 14
        
                The state of Pennsylvania currently has 14 active clinical trials seeking participants for Crohn's Disease research studies. These trials are conducted in various cities, including Philadelphia, Pittsburgh, Hershey and Allentown. 
            
                                Featured Trial
                
                Paid Clinical Studies Nationwide
            
        Recruiting
            
        Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
    
    
Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    
                
                                    Autologous Stem Cell Transplantation for Crohn's Disease
                                
            
            
        Recruiting
                            
            
                The objective of this study is to evaluate the safety and effectiveness of administering high-dose chemotherapy followed by infusion of autologous CD34-selected peripheral blood stem cells (PBSC) in pediatric and adult patients with severe Crohn's disease.             
        
        
    Gender:
                ALL
            Ages:
                Between 10 years and 60 years
            Trial Updated:
                01/07/2025
            
            Locations: UPMC Prebyterian- Adult Gastroenterology, Pittsburgh, Pennsylvania  +1 locations         
        
        
            Conditions: Crohn's Disease
        
            
        
    
                
                                    A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
                                
            
            
        Recruiting
                            
            
                The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of the previous studies. The purpose of this study is to collect the long-term safety of vedolizumab in children with UC or CD.             
        
        
    Gender:
                ALL
            Ages:
                2 years and above
            Trial Updated:
                03/05/2024
            
            Locations: Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania         
        
        
            Conditions: Ulcerative Colitis, Crohn's Disease
        
            
        
    13 - 14 of 14
            